| 12172989 |
Histone acetyltransferase (HAT) inhibitor and use thereof |
Cheng LUO, Hualiang Jiang, Yaxi Yang, Lianghe Mei, Wenchao Lu +5 more |
2024-12-24 |
| 12151204 |
Catalytic oxidation system for efficient conversion and removal of volatile organic compounds (VOCs) in coal chemical industry, and catalytic oxidation method thereof |
Shengyong Lu, Yaqi PENG, Minghui Tang, Kai Zhang, Hao Zhang +2 more |
2024-11-26 |
| 12065447 |
Heterocyclic amide for inhibiting RIP1 kinase and uses thereof |
Wei Tang, Xiangbo Yang, Huimin Lu, Mengying Gao, Yaxi Yang +1 more |
2024-08-20 |
| 11911477 |
Use of fructose in preparing drug for treating ischemic injury |
Xunming JI, Jing Liang, Panpan Yu, Rongrong Han |
2024-02-27 |
| 11548899 |
Fused 1,4-oxazepines and related analogs as BET bromodomain inhibitors |
Shaomeng Wang, Yang Hu, Chao-Yie Yang, Chong Qin |
2023-01-10 |
| 11498927 |
Heterocyclic amide for inhibiting RIP1 kinase and uses thereof |
Wei Tang, Xiangbo Yang, Huimin Lu, Mengying Gao, Yaxi Yang +1 more |
2022-11-15 |
| 11466028 |
Fused 1,4-oxazepines as BET protein degraders |
Shaomeng Wang, Yang Hu, Chong Qin, Fuming Xu, Jiantao Hu +4 more |
2022-10-11 |
| 11427593 |
Bromodomain inhibitor compound and use thereof |
Cheng LUO, Zizhou Li, Yaxi Yang, Shijie Chen, Hong Ding +4 more |
2022-08-30 |
| 11319303 |
Compound used as autophagy regulator, and preparation method therefor and uses thereof |
Cheng LUO, Yuli Xie, Zhiyi Yao, Liyan Yue, Wei Wan +4 more |
2022-05-03 |
| 11192898 |
MDM2 protein degraders |
Shaomeng Wang, Yangbing Li, Jiuling Yang, Angelo Aguilar, Jiantao Hu +3 more |
2021-12-07 |
| 11013745 |
Triazolopyrimidine, triazolopyridine compounds, and the composition thereof for treating PRC2-mediated diseases |
Cheng LUO, Yaxi Yang, Yuanyuan Zhang, Daohai Du, Hualiang Jiang +2 more |
2021-05-25 |
| 10975093 |
Fused 1,4-diazepines as BET protein degraders |
Shaomeng Wang, Yang Hu, Chong Qin, Fuming Xu, Jiantao Hu +1 more |
2021-04-13 |
| 10759808 |
Monofunctional intermediates for ligand-dependent target protein degradation |
Shaomeng Wang, Yangbing Li, Angelo Aguilar, Jiantao Hu, Fuming Xu +8 more |
2020-09-01 |
| 10689434 |
Antibody against hepatitis B surface antigen and use thereof |
Wenxin Luo, Juan Zhang, Quan Yuan, Tianying ZHANG, Jun Zhang +1 more |
2020-06-23 |
| 10633386 |
BET protein degraders |
Shaomeng Wang, Fuming Xu, Jiantao Hu, Longchuan Bai, Chao-Yie Yang |
2020-04-28 |
| 10391175 |
BET bromodomain inhibitors and therapeutic methods using the same |
Shaomeng Wang, Xu Ran, Yujun Zhao, Chao-Yie Yang, Liu Liu +10 more |
2019-08-27 |
| 10307407 |
9H-pyrimido [4,5-B] indoles as BET bromodomain inhibitors |
Shaomeng Wang, Yujun Zhao, Angelo Aguilar |
2019-06-04 |
| 10253044 |
9H-pyrimido [4,5-b]indoles and related analogs as BET bromodomain inhibitors |
Shaomeng Wang, Yujun Zhao, Angelo Aguilar, Liu Liu, Longchuan Bai +11 more |
2019-04-09 |
| 9675697 |
BET bromodomain inhibitors and therapeutic methods using the same |
Shaomeng Wang, Xu Ran, Yujun Zhao, Chao-Yie Yang, Liu Liu +10 more |
2017-06-13 |
| 9580430 |
9H-pyrimido[4,5-B]indoles and related analogs as BET bromodomain inhibitors |
Shaomeng Wang, Yujun Zhao, Angelo Aguilar, Liu Liu, Longchuan Bai +11 more |
2017-02-28 |
| 9403892 |
Therapeutic TRAIL fusion protein and preparation and use thereof |
Yu Zhou, Jing Jiang |
2016-08-02 |
| 8163783 |
Ribonucleotide reductase inhibitors and methods of use |
Yun Yen, David Horne, Yate-Ching Yuan, Angela L. Perkins Harki, Leila Su |
2012-04-24 |
| 7956076 |
Ribonucleotide reductase inhibitors and methods of use |
Yun Yen, David Horne, Yate-Ching Yuan, Angela L. Perkins Harki, Leila Su |
2011-06-07 |
| 7078485 |
N-terminal modified recombinant human endostatin and its production |
Yongzhang Luo, Zhuobing Zhang |
2006-07-18 |
